Jay Meyer

1.4k total citations · 1 hit paper
12 papers, 1.0k citations indexed

About

Jay Meyer is a scholar working on Epidemiology, Economics and Econometrics and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Jay Meyer has authored 12 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Epidemiology, 4 papers in Economics and Econometrics and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Jay Meyer's work include Health Systems, Economic Evaluations, Quality of Life (4 papers), Healthcare Policy and Management (2 papers) and Respiratory viral infections research (2 papers). Jay Meyer is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (4 papers), Healthcare Policy and Management (2 papers) and Respiratory viral infections research (2 papers). Jay Meyer collaborates with scholars based in United States, United Kingdom and Estonia. Jay Meyer's co-authors include James C. Torner, Patricia H. Davis, Thomas N. Taylor, Julia S. Holmes, David A. Stempel, Richard H. Stanford, Stuart Stoloff, Jacqueline R. Carranza Rosenzweig, John C. O’Donnell and Rahul Sasané and has published in prestigious journals such as Stroke, Journal of Allergy and Clinical Immunology and The Journal of Infectious Diseases.

In The Last Decade

Jay Meyer

12 papers receiving 967 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Lifetime Cost of Stroke in the United States

1996 606 citations Thomas N. Taylor, Patricia H. Davis et al. Stroke profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jay Meyer United States	8	338	321	228	183	167	12	1.0k
Sylvie Gabriel United States	24	347 1.0×	120 0.4×	214 0.9×	204 1.1×	141 0.8×	96	1.6k
Frank Lally United Kingdom	12	163 0.5×	135 0.4×	119 0.5×	113 0.6×	89 0.5×	20	668
V. Rao United States	20	613 1.8×	352 1.1×	51 0.2×	38 0.2×	353 2.1×	48	1.6k
Susan L. Hickenbottom United States	13	715 2.1×	203 0.6×	47 0.2×	48 0.3×	324 1.9×	23	1.1k
Signild Åsberg Sweden	18	422 1.2×	94 0.3×	103 0.5×	57 0.3×	161 1.0×	39	1.1k
Arkaitz Galbete Spain	14	68 0.2×	130 0.4×	358 1.6×	98 0.5×	76 0.5×	70	1.0k
Sung‐Hee Yoo South Korea	12	307 0.9×	241 0.8×	122 0.5×	11 0.1×	146 0.9×	32	658
Herbert R. Karp United States	15	333 1.0×	426 1.3×	88 0.4×	56 0.3×	270 1.6×	17	1.1k
Atsuya Shimizu Japan	15	129 0.4×	103 0.3×	102 0.4×	133 0.7×	33 0.2×	89	1.0k
Xianjia Ning China	19	474 1.4×	337 1.0×	82 0.4×	16 0.1×	100 0.6×	98	1.2k

Countries citing papers authored by Jay Meyer

Since Specialization

Citations

This map shows the geographic impact of Jay Meyer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jay Meyer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jay Meyer more than expected).

Fields of papers citing papers by Jay Meyer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jay Meyer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jay Meyer. The network helps show where Jay Meyer may publish in the future.

Co-authorship network of co-authors of Jay Meyer

This figure shows the co-authorship network connecting the top 25 collaborators of Jay Meyer. A scholar is included among the top collaborators of Jay Meyer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jay Meyer. Jay Meyer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

1.

Chalkias, Spyros, Adebayo Akinsola, Gary Berman, et al.. (2025). Safety and Immunogenicity of SARS-CoV-2 Spike Receptor-Binding Domain and N-Terminal Domain mRNA Vaccine. The Journal of Infectious Diseases. 231(4). e754–e763. 7 indexed citations

2.

Meyer, Jay, James Trammel, Yahong Peng, et al.. (2024). A Phase 3, Single-arm Trial to Evaluate the Safety and Immunogenicity of a 20-Valent Pneumococcal Conjugate Vaccine in Healthy Children 15 Months Through <18 Years of Age. The Pediatric Infectious Disease Journal. 43(6). 574–581. 1 indexed citations

3.

Põder, Airi, Jay Meyer, Peter Heymer, et al.. (2023). Immunogenicity and Safety of MF59-Adjuvanted Quadrivalent Influenza Vaccine Compared with a Nonadjuvanted, Quadrivalent Influenza Vaccine in Adults 50–64 Years of Age. Vaccines. 11(10). 1528–1528. 8 indexed citations

4.

Meyer, Jay, et al.. (2005). Patterns and Effectiveness of Lipid-Lowering Therapies in a Managed Care Environment. Value in Health. 8(5). 601–612. 19 indexed citations

5.

O’Donnell, John C., et al.. (2005). Determinants of compliance with statin therapy and low-density lipoprotein cholesterol goal attainment in a managed care population.. PubMed. 11(5). 306–12. 95 indexed citations

6.

Stoloff, Stuart, David A. Stempel, Jay Meyer, Richard H. Stanford, & Jacqueline R. Carranza Rosenzweig. (2004). Improved refill persistence with fluticasone propionate and salmeterol in a single inhaler compared with other controller therapies. Journal of Allergy and Clinical Immunology. 113(2). 245–251. 195 indexed citations

7.

Lee, David W., Jay Meyer, & Jon Clouse. (2001). Implications of Controlling for Comorbid Conditions in Cost-of-Illness Estimates: A Case Study of Osteoarthritis from a Managed Care System Perspective. Value in Health. 4(4). 329–334. 43 indexed citations

8.

Stempel, David A., Jay Meyer, Richard H. Stanford, & Steve Yancey. (2001). One-year claims analysis comparing inhaled fluticasone propionate with zafirlukast for the treatment of asthma. Journal of Allergy and Clinical Immunology. 107(1). 94–98. 33 indexed citations

9.

Lee, David W., Jay Meyer, & Jon Clouse. (2001). Implications of Controlling for Comorbid Conditions in Cost-of-Illness Estimates: A Case Study of Osteoarthritis from a Managed Care System Perspective. Value in Health. 4(4). 329–334. 5 indexed citations

10.

Taylor, Thomas N., et al.. (1996). Lifetime Cost of Stroke in the United States. Stroke. 27(9). 1459–1466. 606 indexed citations breakdown →

11.

Neu, Josef, et al.. (1989). Changes in Phospholipid and Cholesterol Concentrations of the Rat Microvillus Membrane During Maturation. Journal of Pediatric Gastroenterology and Nutrition. 9(1). 89–93. 2 indexed citations

12.

Neu, Josef, et al.. (1989). Changes in Phospholipid and Cholesterol Concentrations of the Rat Microvillus Membrane During Maturation. Journal of Pediatric Gastroenterology and Nutrition. 9(1). 89–93. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact